Comparator: Menactra™ (Non-concomitant)

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

DiphtheriaHuman Papillomavirus InfectionMeningitisNeoplasms, Glandular and EpithelialTetanusWhooping Cough

Phase 3

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

CompletedNCT00325130

Merck Sharp & Dohme LLCDiphtheria, Meningitis, Neoplasms, Glandular and Epithelial +2

Start: 2006-04-30End: 2007-04-30Updated: 2015-03-12

A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)

CompletedNCT00988884

Merck Sharp & Dohme LLCHuman Papillomavirus Infection

Start: 2009-10-21End: 2011-02-22Updated: 2018-12-14